Capricorn Fund Managers’s Rhythm Pharmaceuticals RYTM Stock Holding History

Capricorn Fund Managers’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.78M	Buy	+50,166	New	+$5.35M	0.45%	70

Other funds holding RYTM

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Capricorn Fund Managers's RYTM Position: Q3 2026 in Review

Capricorn Fund Managers opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 50,166 shares worth $4.78M. The stake represents 0.45% of the portfolio and ranks #70 among its holdings.

83 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

Capricorn Fund Managers held 50,166 shares of Rhythm Pharmaceuticals worth $4.78M as of Q3 2026.
Rhythm Pharmaceuticals was a new Capricorn Fund Managers position in Q3 2026.
Rhythm Pharmaceuticals made up 0.45% of Capricorn Fund Managers's portfolio in Q3 2026, its #70 holding.
83 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.